Mission Wealth Management, LP Astrazeneca PLC Transaction History

Mission Wealth Management, LP

$4.24 Billion
Q4 2024

A detailed history of Mission Wealth Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Mission Wealth Management, LP holds 8,577 shares of AZN stock, worth $631,095. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,577

Previous 8,303 3.3%

Holding current value

$631,095

Previous $646,000 13.16%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$63.2 - $79.58 $17,316 - $21,804	274 Added 3.3%	8,577 $561,000
Q3 2024 Oct 31, 2024	BUY	$76.67 - $87.62 $26,221 - $29,966	342 Added 4.3%	8,303 $646,000
Q2 2024 Aug 02, 2024	BUY	$66.81 - $80.83 $89,324 - $108,069	1,337 Added 20.18%	7,961 $620,000
Q1 2024 Apr 30, 2024	SELL	$61.03 - $69.57 $229,533 - $261,652	-3,761 Reduced 36.22%	6,624 $448,000
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $140,861 - $157,681	2,276 Added 28.07%	10,385 $699,000
Q3 2023 Oct 23, 2023	BUY	$64.85 - $71.7 $133,655 - $147,773	2,061 Added 34.08%	8,109 $549,000
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $5,732 - $6,216	-82 Reduced 1.34%	6,048 $432,000
Q1 2023 Apr 07, 2023	BUY	$63.15 - $71.6 $19,197 - $21,766	304 Added 5.22%	6,130 $425,000
Q4 2022 Feb 02, 2023	BUY	$54.21 - $70.44 $12,251 - $15,919	226 Added 4.04%	5,826 $395,000
Q3 2022 Oct 12, 2022	BUY	$53.02 - $135.75 $20,995 - $53,757	396 Added 7.61%	5,600 $307,000
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $1,718 - $2,063	29 Added 0.56%	5,204 $344,000
Q1 2022 Apr 25, 2022	SELL	$55.72 - $67.12 $5,404 - $6,510	-97 Reduced 1.84%	5,175 $343,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $4,159 - $4,914	-77 Reduced 1.44%	5,272 $307,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $56,004 - $61,276	1,008 Added 23.22%	5,349 $321,000
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $21,256 - $26,419	-439 Reduced 9.18%	4,341 $260,000
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $23,155 - $26,730	491 Added 11.45%	4,780 $238,000
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $26,249 - $31,388	541 Added 14.43%	4,289 $214,000
Q3 2020 Oct 16, 2020	BUY	$53.07 - $61.1 $198,906 - $229,002	3,748 New	3,748 $205,000

Others Institutions Holding AZN

# of Institutions

1,351

Shares Held

489M

Call Options Held

5.88M

Put Options Held

4.1M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.

Account

Mission Wealth Management, LP Astrazeneca PLC Transaction History